|
Sodium picosulfate M1Z1
|
匹可硫酸鈉M1Z1
|
16985-05-0
|
|
Deoxysepiapterin
|
脫氧半胱氨酸
|
1797-87-1
|
|
3R, 5R epimer (impurity b)
|
3R,5R差向異構(gòu)體（雜質(zhì)B）
|
|
|
Salkeliptin impurity k
|
沙克列汀雜質(zhì)K
|
|
|
Salkeliptin impurity q
|
沙克列汀雜質(zhì)Q
|
|
|
Omadacycline Impurity 3YWP-IM-03
|
奧瑪環(huán)素雜質(zhì)YWP-IM-03
|
2272886-35-6
|
|
Amlodipine Impurity D
|
氨氯地平雜質(zhì)D
|
113994-41-5
|
|
Levofloxacin Impurity D
|
左氧氟沙星雜質(zhì)D
|
178964-53-9
|
|
Ceftriaxone EP impurity A
|
頭孢曲松鈉EP雜質(zhì)A
|
97164-54-0
|
|
Bupropion Related Compound A HCl
|
安非他酮雜質(zhì) A HCl
|
1049718-72-0
|
|
Nicergoline Impurity A
|
尼麥角林EP雜質(zhì)A
|
38536-28-6
|
|
Linezolid ImpurityLNZA-E
|
利奈唑胺雜質(zhì)LNZA-E
|
1391068-25-9
|
|
Calcium Levofolinate Impurity
|
葉酸鈣雜質(zhì)
|
39707-61-4
|
|
Lysine Acetylsalicylate Impurity H
|
賴氨匹林EP雜質(zhì)H
|
121893-23-0
|
|
formaldehyde O-methyl oxime
|
O-甲基甲醛肟
|
62479-73-6
|
|
Trimetazidine Impurity
|
曲美他嗪亞硝胺雜質(zhì)
|
92432-50-3
|
|
Salkeliptin impurity b
|
沙克列汀雜質(zhì)B
|
|
|
Salkeliptin impurity h
|
沙克列汀雜質(zhì)H
|
|
|
Omadacycline Impurity 2YWP-IM-02
|
奧瑪環(huán)素雜質(zhì)YWP-IM-02
|
885112-31-2
|
|
Tryptophan EP Impurity F
|
色氨酸EP雜質(zhì)F
|
145545-23-9
|
|
Diltiazem EP Impurity B
|
地爾硫卓EP雜質(zhì)B
|
87447-47-0
|
|
5,6-trans Travoprost
|
5,6-反式-曲伏前列素
|
1563176-59-9
|
|
Afzosin hydrochloride impurity e
|
鹽酸阿夫唑嗪雜質(zhì)E
|
|
|
Apatamide impurity 2
|
阿帕他胺雜質(zhì)2
|
133239-92-0
|
|
Argatroban Impurity I
|
阿加曲班雜質(zhì)I
|
189264-02-6
|
|
2-Hydroxypropylcarbamate
|
碳13尿 2-羥丙基氨基甲酸酯
|
17464-96-9
|
|
Ilaprazole Impurity
|
艾普拉唑雜質(zhì)
|
1378653-43-0
|
|
3S, 5S epimer (impurity b)
|
3S,5S差向異構(gòu)體（雜質(zhì)B）
|
|
|
Afzosin hydrochloride impurity a
|
鹽酸阿夫唑嗪雜質(zhì)A
|
|
|
Salkeliptin impurity o
|
沙克列汀雜質(zhì)O
|
|
|
Sugammadex Org226100-1
|
舒更葡糖鈉雜質(zhì)18 Org226100-1
|
2768160-22-9
|
|
Vitamin K1 Impurity G
|
維生素K1雜質(zhì)G
|
34044-00-3
|
|
1-Propanol, 2-(2-hydroxypropoxy)-, 1-carbamate
|
碳13尿 3-(2-羥基丙氧基)丙基氨基甲酸酯
|
2271317-97-4
|
|
1-hydroxypropyl-2-yl-Carbamate
|
碳13尿 1-羥丙基-2-基-氨基甲酸酯
|
36473-03-7
|
|
Linagliptin Impurity 106
|
利格列汀雜質(zhì)106
|
1955514-80-3
|
|
Decarbamoylcefoxitin Cefoxitin Impurity E
|
頭孢西丁雜質(zhì)E
|
2395025-32-6
|
|
Empagliflozin Impurity 25
|
恩格列凈雜質(zhì) 25
|
2452301-42-5
|
|
Starting material II (impurity n)
|
起始原料Ⅱ（雜質(zhì)N）
|
|
|
Salkeliptin impurity l
|
沙克列汀雜質(zhì)L
|
|
|
Salkeliptin impurity r
|
沙克列汀雜質(zhì)R
|
|
|
Omadacycline Impurity 1YWP-IM-01
|
奧瑪環(huán)素雜質(zhì)YWP-IM-01
|
601455-29-2
|
|
Duloxetine Related Compound H
|
鹽酸度洛西汀雜質(zhì)H
|
199191-66-7
|
|
Bupropion Related Compound B HCl
|
安非他酮雜質(zhì) B HCl
|
1049718-43-5
|
|
Salbutamol Impurity L
|
鹽酸左旋沙丁胺醇雜質(zhì)L
|
149222-15-1
|
|
Dapagliflozin peroxide impurit
|
達(dá)格列凈過氧化物雜質(zhì)
|
2452300-94-4
|
|
Salkeliptin impurity c
|
沙克列汀雜質(zhì)C
|
|
|
Salkeliptin impurity i
|
沙克列汀雜質(zhì)I
|
|
|
2-(((5-methoxy-1H-benzo[d]imidazol-2-yl)sulfinyl)methyl)-3,5-dimethylpyridin-4(1H)-one
|
艾司奧美拉唑雜質(zhì)5
|
301669-82-9
|
|
(3R,5S)-7-[2-cyclopropyl-4-(4-fluorophenyl)-3-quinolyl]-3,5-dihydrosy-6-heptane acid,(+)phenyl ethylamine
|
匹伐他汀雜質(zhì)
|
147511-70-4
|
|
Atorvastatin Impurity
|
阿托伐他汀內(nèi)酰胺雜質(zhì)
|
906552-18-9
|
|
BOlmesartan Medoxomil EP Impurity B
|
奧美沙坦酯脂EP雜質(zhì)B
|
849206-43-5
|
|
Ezetimibe tetrahydropyran Impurity 56
|
依折麥布四氫呋喃雜質(zhì)56
|
1296129-15-1
|
|
Oseltamivir Impurity
|
奧司他韋雜質(zhì)
|
1415963-60-8
|
|
Brexpiprazole Impurity
|
二氫布瑞哌唑
|
913612-07-4
|
|
Lubiprostone enantioMer Impurity
|
蘆比前列酮對(duì)映異構(gòu)體
|
1217675-13-2
|
|
Upadacitinib Impurity 15
|
烏帕替尼雜質(zhì)15
|
2304514-60-9
|
|
Indapamide Impurity A
|
吲達(dá)帕胺雜質(zhì)A
|
85440-79-5
|
|
Demethylation impurity
|
脫甲基雜質(zhì)
|
|
|
Salkeliptin impurity e
|
沙克列汀雜質(zhì)E
|
|
|
Salkeliptin impurity
|
沙克列汀雜質(zhì)
|
361442-04-8
|
|
Levofloxacin N-oxide
|
左氧氟沙星N-氧化物
|
117678-38-3
|
|
Betahistine Impurity 9
|
倍他司汀雜質(zhì)9
|
6304-27-4
|
|
Esomeprazole Impurity
|
埃索美拉唑雜質(zhì)
|
2362529-32-4
|
|
Rosuvastatin tert butyl propionate (impurity f)
|
瑞舒伐他汀丙叉叔丁酯（雜質(zhì)F）
|
|
|
Salkeliptin impurity m
|
沙克列汀雜質(zhì)M
|
|
|
Paliperidone Impurity
|
棕櫚酸帕利哌酮光降解雜質(zhì)
|
913728-83-3
|
|
Urea, N-(1-hydroxyethyl)-
|
碳13尿 1-(2-羥丙基)脲
|
16395-94-1
|
|
Sulbactam Impurity C
|
舒巴坦雜質(zhì)C
|
75527-87-6
|
|
Afzosin hydrochloride impurity D
|
鹽酸阿夫唑嗪雜質(zhì)D
|
|
|
Ticagrelor Impurity SIP-1
|
替格瑞洛雜質(zhì)SIP-1
|
2096989-56-7
|
|
Mometasone Furoate EP Impurity H
|
糠酸莫米松EP雜質(zhì)H
|
148596-90-1
|
|
Ethyl Lipoicate Impurity
|
硫辛酸乙酯雜質(zhì)
|
46353-61-1
|
|
1,1,5,5-Tetramethyl-2-(1-methylethenyl)cyclohexane
|
1,1,5,5-四甲基-2-(1-甲基乙烯基)環(huán)己烷
|
63251-38-7
|
|
Salkeliptin impurity d
|
沙克列汀雜質(zhì)D
|
|
|
Salkeliptin impurity j
|
沙克列汀雜質(zhì)J
|
|
|
Salkeliptin impurity p
|
沙克列汀雜質(zhì)P
|
|
|
Linagliptin Impurity V
|
利格列汀雜質(zhì) V
|
2468656-63-3
|
|
Omadacycline Impurity 6YWP-IM-06
|
奧瑪環(huán)素雜質(zhì)YWP-IM-06
|
488819-64-3
|
|
Atorvastatin Calcium Impurity Ⅵ
|
阿托伐他汀鈣雜質(zhì)VI降解物
|
873590-19-7
|
|
Dapagliflozin Impurity A
|
達(dá)格列凈雜質(zhì)A
|
1373321-04-0
|
|
Norepinephrine Impurity 9
|
去甲腎上腺素雜質(zhì)9
|
1891319-98-4
|
|
Afzosin hydrochloride impurity
|
鹽酸阿夫唑嗪雜質(zhì)
|
81403-68-1
|
|
Salkeliptin impurity f
|
沙克列汀雜質(zhì)F
|
|
|
Salkeliptin impurity a
|
沙克列汀雜質(zhì)A
|
|
|
Salkeliptin impurity g
|
沙克列汀雜質(zhì)G
|
|
|
ValsartanEP Impurity A
|
纈沙坦對(duì)映異構(gòu)體
|
137862-87-4
|
|
Levonorgestrel Impurity 5
|
左炔諾孕酮雜質(zhì)5
|
17092-07-8
|
|
Clavulanic acid Impurity C
|
克拉維酸雜質(zhì)C
|
86917-74-0
|
|
Afzosin hydrochloride impurity B
|
鹽酸阿夫唑嗪雜質(zhì)B
|
|
|
Cefaclor EP Impurity C
|
頭孢克洛EP雜質(zhì)C
|
143059-69-2
|
|
Azacitidine α-Isomer Impurity
|
阿扎胞苷a-異構(gòu)體雜質(zhì)
|
157771-77-2
|
|
Bisoprolol Hydroxyethyl Ester Impurity D
|
比索洛爾羥乙酯雜質(zhì)D
|
1346601-19-1
|
|
Vonoprazan Impurity Imp-47
|
伏諾拉生雜質(zhì)Imp-47
|
2416241-97-7
|
|
Amlodipine EP Impurity D
|
氨氯地平EP雜質(zhì)D
|
2138811-33-1
|
|
Epalrestat (E,E)-Isomer
|
依帕司他異構(gòu)體(E,E)對(duì)照品
|
863988-85-6
|
|
DL-Pantothenic acid calcium salt
|
DL泛酸鈣
|
6381-63-1
|
|
Enantiomer (impurity g)
|
對(duì)映異構(gòu)體（雜質(zhì)G）
|
|
|
Tert butyl rosuvastatin (impurity m)
|
瑞舒伐他汀叔丁酯（雜質(zhì)M）
|
|
|
Salkeliptin impurity n
|
沙克列汀雜質(zhì)N
|
|